Uses doctor-performance data to cut employer health costs; raised $100M at a $2.7B valuation in May 2026.
Healthcare
Current Valuation
$2.7B
as of 2026-05
UNICORN
QL Price
$2.7B
0% vs last round
QuantLogix's current estimate for Garner Health, published 2026-10-14 — in line with the last disclosed round of $2.7B (2026-05).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$2.7B
2026-05
weight 0.73
How this price has held up
No round has priced for Garner Health since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-10-14 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Garner Health, 2026-10-14 (a06ed0159ac5a46e).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Garner Health going public?
No. Garner Health is private and has not filed to go public. There is no S-1 on file.
What is Garner Health's valuation in 2026?
Garner Health is valued at $2.7B as of May 2026, set by its Venture ($100M, May 2026). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Garner Health filed an S-1?
No public S-1 is on file for Garner Health.
Is Garner Health publicly traded — can you buy Garner Health stock?
No. Garner Health is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Garner Health on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Last Round
Venture — $100M (May 2026)
IPO Status
Private
Fundraising Status
Venture · $100M · 5 mo ago
Private1 disclosed rounds
Venture Impact
Round Size
$100M
Primary financing announced
Post-Money Valuation
$2.7B
Company-announced mark
Round / Post-Money
3.7%
New capital ÷ post-money
Step-up compares disclosed post-money valuations. Round / post-money is a financing-size ratio, not an ownership or dilution estimate.
Funding History
Round
Amount
Date
Lead Investor
Post-Money
Venture
$100M
May 2026
—
$2.7B
Talent Signal
Hiring trend
▶ Hiring steady
-6% vs 2026-08
Open roles
76
via greenhouse
Product-build share
43%
engineering, research, product, design
Trajectory
steady
balanced build + GTM — 43% builders vs 57% go-to-market/G&A — scaling both sides.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Applied Scientist IIIApplied Scientist IIIAssociate Applied ScientistAssociate Software EngineerData Analyst II, Business InsightsData Analyst III, Reporting & Analytics
Counted from Garner Health's live job board as of 2026-09-27; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
HealthcareData
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2026-05. Refreshed quarterly.